Literature DB >> 25150510

Correction of hyponatremia and osmotic demyelinating syndrome: have we neglected to think intracellularly?

Phuong-Mai T Pham1, Phuong-Anh T Pham2, Son V Pham3, Phuong-Truc T Pham4, Phuong-Thu T Pham5, Phuong-Chi T Pham6.   

Abstract

BACKGROUND: Osmotic demyelination syndrome (ODS) is a complication generally associated with overly rapid correction of hyponatremia. Traditionally, nephrologists have been trained to focus solely on limiting the correction rate. However, there is accumulating evidence to suggest that the prevention of ODS is beyond achieving slow correction rates.
METHODS: We (1) reviewed the literature for glial intracellular protective alterations during hyperosmolar stress, a state presumed equivalent to the rapid correction of hyponatremia, and (2) analyzed all available hyponatremia-associated ODS cases from PubMed for possible contributing factors including correction rates and concurrent metabolic disturbances involving hypokalemia, hypophosphatemia, hypomagnesemia, and/or hypoglycemia.
RESULTS: In response to acute hyperosmolar stress, glial cells undergo immediate extracellular free water shift, followed by active intracellular Na(+), K(+) and amino acid uptake, and eventual idiogenic osmoles synthesis. At minimum, protective mechanisms require K(+), Mg(2+), phosphate, amino acids, and glucose. There were 158 cases of hyponatremia-associated ODS where both correction rates and other metabolic factors were documented. Compared with the rapid correction group (>0.5 mmol/L/h), the slow correction group (≤0.5 mmol/L/h) had a greater number of cases with concurrent hypokalemia (49.4 vs. 33.3 %, p = 0.04), and a greater number of cases with any concurrent metabolic derangements (55.8 vs. 38.3 %, p = 0.03).
CONCLUSION: Glial cell minimizes volume changes and injury in response to hyperosmolar stress via mobilization and/or utilization of various electrolytes and metabolic factors. The prevention of ODS likely requires both minimization of correction rate and optimization of intracellular response during the correction phase when a sufficient supply of various factors is necessary.

Entities:  

Keywords:  Folate; Hypoglycemia; Hypokalemia; Hypomagnesemia; Hypophosphatemia; Thiamine

Mesh:

Substances:

Year:  2014        PMID: 25150510     DOI: 10.1007/s10157-014-1021-y

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  38 in total

1.  Overcorrection of hyponatremia: where do we go wrong?

Authors:  P C Pham; P V Chen; P T Pham
Journal:  Am J Kidney Dis       Date:  2000-08       Impact factor: 8.860

2.  Central pontine myelinolysis temporally related to hypophosphataemia.

Authors:  A W Michell; D J Burn; P J Reading
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-06       Impact factor: 10.154

3.  Central pontine myelinolysis associated with acquired folate depletion.

Authors:  V T Ramaekers; J Reul; G Kusenbach; A Thron; G Heimann
Journal:  Neuropediatrics       Date:  1997-04       Impact factor: 1.947

4.  Hypoglycemia influences oligodendrocyte development and myelin formation.

Authors:  Henglin Yan; Scott A Rivkees
Journal:  Neuroreport       Date:  2006-01-23       Impact factor: 1.837

Review 5.  The role of the neutral amino acid transporter SNAT2 in cell volume regulation.

Authors:  R Franchi-Gazzola; V Dall'Asta; R Sala; R Visigalli; E Bevilacqua; F Gaccioli; G C Gazzola; O Bussolati
Journal:  Acta Physiol (Oxf)       Date:  2006 May-Jun       Impact factor: 6.311

6.  Hyperosmolality-induced GABA release from rat brain slices: studies of calcium dependency and sources of release.

Authors:  P H Chan; Y P Wong; R A Fishman
Journal:  J Neurochem       Date:  1978-06       Impact factor: 5.372

7.  Effect of acute hyponatremia on rat brain pH and rat brain buffering.

Authors:  S Adler; V Simplaceanu
Journal:  Am J Physiol       Date:  1989-01

8.  Potassium homeostasis and clinical implications.

Authors:  R S Brown
Journal:  Am J Med       Date:  1984-11-05       Impact factor: 4.965

Review 9.  Osmotic demyelination syndrome following correction of hyponatremia: association with hypokalemia.

Authors:  J W Lohr
Journal:  Am J Med       Date:  1994-05       Impact factor: 4.965

10.  Effects of hypernatremia on organic brain osmoles.

Authors:  Y H Lien; J I Shapiro; L Chan
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

View more
  7 in total

1.  Osmotic Demyelination Syndrome following Correction of Hyponatremia by ≤10 mEq/L per Day.

Authors:  Srijan Tandukar; Richard H Sterns; Helbert Rondon-Berrios
Journal:  Kidney360       Date:  2021-07-08

Review 2.  Clinical Implications, Evaluation, and Management of Hyponatremia in Cirrhosis.

Authors:  Dibya L Praharaj; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2021-09-16

3.  Caudal and Lentiform nuclei Myelinolysis following Endoscopical surgery for pediatric Craniopharyngioma: two cases report and literature review.

Authors:  Zhi Gang Wang; Lian Ying Jiang; Wen Hao Zhang; Tao Hong
Journal:  Chin Neurosurg J       Date:  2018-06-27

Review 4.  Challenging management dogma where evidence is non-existent, weak or outdated.

Authors:  Daniel A Hofmaenner; Mervyn Singer
Journal:  Intensive Care Med       Date:  2022-03-18       Impact factor: 41.787

5.  Therapeutic Approach to the Management of Severe Asymptomatic Hyponatremia.

Authors:  Thaofiq Ijaiya; Sandhya Manohar; Kameswari Lakshmi
Journal:  Case Rep Nephrol       Date:  2017-07-27

6.  Multiple Electrolyte and Metabolic Emergencies in a Single Patient.

Authors:  Caprice Cadacio; Phuong-Thu Pham; Ruchika Bhasin; Anita Kamarzarian; Phuong-Chi Pham
Journal:  Case Rep Nephrol       Date:  2017-01-31

Review 7.  Osmotic Demyelination: From an Oligodendrocyte to an Astrocyte Perspective.

Authors:  Charles Nicaise; Catherine Marneffe; Joanna Bouchat; Jacques Gilloteaux
Journal:  Int J Mol Sci       Date:  2019-03-05       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.